Last edition
News about "Oral Suspension"
Biocon Receives US FDA Approval for Everolimus Tablets for Oral Suspension
Biocon has secured US FDA approval for Everolimus Tablets for Oral Suspension, enhancing its portfolio of vertically integrated drug products and expanding treatment options for patients in key markets.
Oral Suspension | 13/01/2026 | By News Bureau
Lupin Receives Approval from US FDA for Rivaroxaban for Oral Suspension
Lupin’s Rivaroxaban will be manufactured at the company’s Chhatrapati Sambhajinagar facility.
Oral Suspension | 01/10/2025 | By Dineshwori | 255
Lupin Gets Approval from FDA for Abacavir, Dolutegravir and Lamivudine Tablets
Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension, 60 mg/5 mg/30 mg, (RLD Triumeq PD) had an estimated annual sale of USD 1.3 million in the US.
Oral Suspension | 06/12/2024 | By Aishwarya | 603
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy